Affordable Access

deepdyve-link
Publisher Website

Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).

Authors
  • Shibui, Soichiro
  • Narita, Yoshitaka
  • Mizusawa, Junki
  • Beppu, Takaaki
  • Ogasawara, Kuniaki
  • Sawamura, Yutaka
  • Kobayashi, Hiroyuki
  • Nishikawa, Ryo
  • Mishima, Kazuhiko
  • Muragaki, Yoshihiro
  • Maruyama, Takashi
  • Kuratsu, Junichi
  • Nakamura, Hideo
  • Kochi, Masato
  • Minamida, Yoshio
  • Yamaki, Toshiaki
  • Kumabe, Toshihiro
  • Tominaga, Teiji
  • Kayama, Takamasa
  • Sakurada, Kaori
  • And 20 more
Type
Published Article
Journal
Cancer Chemotherapy and Pharmacology
Publisher
Springer-Verlag
Publication Date
Feb 01, 2013
Volume
71
Issue
2
Pages
511–521
Identifiers
DOI: 10.1007/s00280-012-2041-5
PMID: 23228988
Source
Medline
License
Unknown

Abstract

The addition of PCZ to ACNU was not beneficial, in comparison with ACNU alone, for patients with newly diagnosed AA and GBM.

Report this publication

Statistics

Seen <100 times